DDR1 and neoplasm: An independent study [74] in a cohort of 83 lung cancer specimens found that silencing of DDR1 in these samples leads to the hampering of cell survival, reduced invasiveness in collagen matrices, increased apoptosis in basal condition and decreased metastatic activity in model of tumor metastasis to bone, signifying it as a potential novel therapeutic target.